Newsfeeds - Spark Newswire

1 minute read

These Are The Top Companies And Most Influential People In The Psychedelics Space: Meet The Winners Of The Microdose Awards

Today, 12:28 PM

Which are the top companies and who are the most influential people in the psychedelics space? According to Microdose Psychedelic Insights, host of the Microdose Awards, these are the ones to watch.

ATAI

4 minute read

EXCLUSIVE: Insider’s Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance

By Lara Goldstein

Today, 12:28 PM

(Part four of a four-part series) See previous stories in this series:

ATAI

3 minute read

EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says ‘Potential Reward Is Immeasurable’

By Javier Hasse

Today, 12:28 PM

Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a general partner, Benzin

$USDT

5 minute read

EXCLUSIVE: Insider’s Peek At Mammoth Of Psychedelics VCs, Palo Santo’s Investment Fundamentals & Specificities

By Lara Goldstein

Today, 12:28 PM

(Part one of a four-part series)

ATAI

3 minute read

A Sinister Reason May Be Behind Governors’ Opposition To Cannabis Legalization

By Maureen Meehan

Today, 12:28 PM

As one Republican governor after another rejects President Biden’s suggestion to pardon simple cannabis possession convictions, one wonders what they're thinking.

ATAI

2 minute read

Atai’s Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon

By Lara Goldstein

Today, 12:28 PM

Clinical stage psychedelics company atai Life Sciences (NASDAQ: ATAI) and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing the safety and efficacy of a single intravenous infusion (IV) dose of proprietary R-ketamine PCN-101 for patients

ATAI